DRONABINOL

Post-LOE

dronabinol

ANDAORALCAPSULE
Approved
Feb 2020
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
4

Mechanism of Action

12.1 Mechanism of Action Dronabinol is an orally active cannabinoid which has complex effects on the CNS, including central sympathomimetic activity. Cannabinoid receptors have been discovered in neural tissues. These receptors may play a role in mediating the effects of dronabinol. 12.2…

Pharmacologic Class:

Cannabinoid

Clinical Trials (4)

NCT05612711Phase 2Withdrawn

Dronabinol for Agitation in Dementia Crossover Trial

Started Nov 2023
0
Dementia ModerateDementia SevereAgitation,Psychomotor+1 more
NCT00123201Phase 2Completed

Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache

Started Sep 2005
NCT00176163Phase 2Completed

Supporting Effect of Dronabinol on Behavioral Therapy in Fibromyalgia and Chronic Back Pain

Started Aug 2005
240 enrolled
FibromyalgiaBack Pain
NCT00000737Phase 1Completed

A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome

56 enrolled
CachexiaHIV InfectionsHIV Wasting Syndrome